OpenAI's CFO, Sarah Friar, has outlined the company's move towards new revenue models beyond traditional software subscriptions.

She described the exploration of licensing models that tie financial returns to customer outcomes, particularly in sectors like pharmaceuticals.

Friar emphasized the potential for partnerships where OpenAI could receive a percentage of revenue generated from breakthroughs facilitated by its technology, such as new drug discoveries.

Source: businessinsider.com